anti-basigin blood stage vaccine (Wellcome Trust Sanger Institute)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-basigin blood stage vaccine (Wellcome Trust Sanger Institute)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBasigin inhibitors
TargetsBasigin
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWellcome Trust
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWellcome Trust
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A